SAGENT PHARMACEUTICALS INC COM STK (DE)
SGNT
SGNT was delisted on the 29th of August, 2016.
127 hedge funds and large institutions have $385M invested in SAGENT PHARMACEUTICALS INC COM STK (DE) in 2015 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 55 increasing their positions, 43 reducing their positions, and 28 closing their positions.
2,513% more call options, than puts
Call options by funds: $392K | Put options by funds: $15K
28% more repeat investments, than reductions
Existing positions increased: 55 | Existing positions reduced: 43
7% less funds holding
Funds holding: 136 → 127 (-9)
32% less first-time investments, than exits
New positions opened: 19 | Existing positions closed: 28
36% less capital invested
Capital invested by funds: $604M → $385M (-$219M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Scopia Capital Management
New York
|
+$23.7M |
| 2 |
EAM
EverPoint Asset Management
Stamford,
Connecticut
|
+$22.7M |
| 3 |
TAM
THB Asset Management
Norwalk,
Connecticut
|
+$10.1M |
| 4 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
+$7.93M |
| 5 |
HM
HealthCor Management
New York
|
+$7.3M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Acadian Asset Management
Boston,
Massachusetts
|
-$17.9M |
| 2 |
RIM
Ranger Investment Management
Dallas,
Texas
|
-$17.4M |
| 3 |
SAM
Senzar Asset Management
New York
|
-$11M |
| 4 |
SFM
Soros Fund Management
New York
|
-$8.44M |
| 5 |
Franklin Resources
San Mateo,
California
|
-$6.09M |
SGNT Hedge Fund Activity: Q3 2015 in Review
127 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) for Q3 2015, worth a combined $385M — down 36% from $604M a quarter earlier.
Sellers outnumbered buyers: 28 funds closed out of SGNT and 19 opened new positions — a net loss of 9 holders — while 43 trimmed existing stakes and 55 added.
The largest buyer was Scopia Capital Management, opening a new position worth an estimated $23.7M. The largest seller was Acadian Asset Management, cutting an estimated $17.9M.
- 127 institutional investors held SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) as of Q3 2015, down from 136 in Q2 2015.
- Funds reported $385M of SAGENT PHARMACEUTICALS INC COM STK (DE) stock for Q3 2015, down 36% quarter-over-quarter.
- 19 funds opened new SAGENT PHARMACEUTICALS INC COM STK (DE) positions in Q3 2015 and 28 closed out, a net change of -9 holders.
- The largest SAGENT PHARMACEUTICALS INC COM STK (DE) buyer in Q3 2015 was Scopia Capital Management, an estimated $23.7M added.
- The largest SAGENT PHARMACEUTICALS INC COM STK (DE) seller in Q3 2015 was Acadian Asset Management, an estimated $17.9M sold.
Based on aggregated 13F filings for Q3 2015.